KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Depreciation Accumulated Expenses Assets Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Liabilities and Shareholders Equity Long-Term Investments Minority Interest Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Accured Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

Vir Biotechnology (VIR) Pension (2019 - 2020)

Vir Biotechnology's Pension history spans 2 years, with the latest figure at $2.9 million for Q4 2020.

On a quarterly basis, Pension rose 52.63% to $2.9 million in Q4 2020 year-over-year; TTM through Dec 2020 was $2.9 million, a 52.63% increase, with the full-year FY2020 number at $2.9 million, up 52.63% from a year prior.
Pension hit $2.9 million in Q4 2020 for Vir Biotechnology, up from $1.9 million in the prior quarter.
Over the last five years, Pension for VIR hit a ceiling of $2.9 million in Q4 2020 and a floor of $1.9 million in Q4 2019.